Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome

Fertility and Sterility

Volumn 96, Issue 4, 2011, Pages 1043-1047

  Hurd, William W ^a   Abdel Rahman, Mohamed Y ^a,c   Ismail, Salah A ^c   Abdellah, Mostafa A ^c   Schmotzer, Christine L ^b   Sood, Ajay ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sohag University   (Egypt)

Author keywords

blood glucose; hemoglobin A1c; insulin resistance; oral glucose tolerance test; Polycystic ovarian syndrome; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; FASTING PLASMA GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MASS SCREENING; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80053305605     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.07.002     Document Type: Article

References (31)

1. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749 (Pubitemid 38766360)
2. F. Ovalle, and R. Azziz Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus Fertil Steril 77 2002 1095 1105 (Pubitemid 34626313)
3. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174 (Pubitemid 19250404)
4. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, and W. Futterweit Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2010 2038 2049
5. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, and R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078 3082 (Pubitemid 28500937)
6. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245 (Pubitemid 44833391)
7. E. Diamanti-Kandarakis, F. Economou, S. Palimeri, and C. Christakou Metformin in polycystic ovary syndrome Ann N Y Acad Sci 1205 2010 192 198
8. D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, and J. Imperial Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146 (Pubitemid 29028311)
9. K.E. Salley, E.P. Wickham, K.I. Cheang, P.A. Essah, N.W. Karjane, and J.E. Nestler Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society J Clin Endocrinol Metab 92 2007 4546 4556 (Pubitemid 350223423)
10. ACOG Committee on Practice Bulletins - Gynecology ACOG Practice Bulletin No. 108: Polycystic ovary syndrome Obstet Gynecol 114 2009 936 949
11. American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee American Association of Clinical Endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome Endocr Pract 11 2005 126 134
12. American Diabetes Association Standards of medical care in diabetes - 2010 Diabetes Care 33 2010 S11 S61
13. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
14. American Diabetic Association Consensus Development Conference on Insulin Resistance Diabetes Care 21 1998 310 314
15. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495 (Pubitemid 38680001)
16. J.E. Nestler, D. Stovall, N. Akhter, M.J. Iuorno, and D.J. Jakubowicz Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome Fertil Steril 77 2002 209 215 (Pubitemid 34083541)
17. R.P. Kauffman, V.M. Baker, P. Dimarino, T. Gimpel, and V.D. Castracane Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations Am J Obstet Gynecol 187 2002 1362 1369 (Pubitemid 35397487)
18. E.S. Kang, Y.S. Yun, S.W. Park, H.J. Kim, C.W. Ahn, and Y.D. Song Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea Metabolism 54 2005 206 211 (Pubitemid 40174849)
19. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
20. M.J. Gillett International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
21. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
22. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, and G. Targher Prevalence of insulin resistance in metabolic disorders: the Bruneck Study Diabetes 47 1998 1643 1649 (Pubitemid 28445355)
23. Clinical Guidelines on the Identification Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health Obes Res 6 1998 S51 S209
24. Food and Drug Administration. Statistical guidance on reporting results from studies evaluating diagnostic tests. Rockville, MD: Food and Drug Administration, 2007. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm071148.htm.
25. W. Vach The dependence of Cohen's kappa on the prevalence does not matter J Clin Epidemiol 58 2005 655 661 (Pubitemid 40797894)
26. C.M. Bennett, M. Guo, and S.C. Dharmage HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review Diabet Med 24 2007 333 343 (Pubitemid 46452406)
27. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169 (Pubitemid 29036695)
28. R.S. Legro, D. Finegood, and A. Dunaif A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome J Clin Endocrinol Metab 83 1998 2694 2698 (Pubitemid 28493762)
29. E. Carmina, and R.A. Lobo Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome Fertil Steril 82 2004 661 665 (Pubitemid 39243189)
30. H.W. Rodbard, L. Blonde, S.S. Braithwaite, E.M. Brett, R.H. Cobin, and Y. Handelsman American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus Endocr Pract 13 Suppl 1 2007 1 68
31. M. Möhlig, A. Flöter, J. Spranger, M.O. Weickert, T. Schill, and H.W. Schlösser Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling Diabetologia 49 2006 2572 2579